BioPharma Pharma Research
AstraZeneca Collaborates with Cholesgen for Hypercholesterolemia Drug Discovery and Licensing Agreement
This three-year collaboration aims to validate genetic drug targets and progress therapeutic molecules into clinical development. The joint resea...
June 19, 2023 | News
Gilead Sciences Singapore Discusses Access and Affordability of CAR T-Cell Therapy in Singapore and Beyond
Can you elaborate on the current availability and accessibility of CAR T-cell therapies in Singapore? What are the key considerations or barriers that need...
June 19, 2023 | News
Chinese Medical Development Led by Hong Kong Dragon's Medical and Reproductive Giants
Dragon's Medical successfully held its Advance Medical Technology Press Conference 2023 at W Hong Kong, signing strategic partnership agreements with ...
June 12, 2023 | News
Merck Announces Proteologix as Winner of its North American Advance Biotech Grant
Proteologix to receive in-kind products and services to develop treatments for autoimmune/inflammatory diseases and oncology indications Experts from Me...
June 07, 2023 | News
Biosyngen's Cell Therapy BRG01 Receives FDA Orphan Drug Designation for Nasopharyngeal Cancer Treatment
The FDA Orphan Drug Designation program grants orphan status to promising investigation drugs or biological products designed to treat, prevent or diagnose...
June 07, 2023 | News
Massive Bio and TOI Partner to Revolutionize Cancer Care and Research
Under this visionary collaboration, Massive Bio will support TOI with evaluating the eligibility of patients for TOI's active clinical ...
June 05, 2023 | News
Aravax doses first patient in Phase 2 peanut allergy clinical trials
Allergy clinical trial centres across Victoria, South Australia, New South Wales, and Western Australia have invited children and ...
June 02, 2023 | News
GC Biopharma Licensed to Build Plasma Fractionation Plant in Indonesia
GC Biopharma, a South Korean biopharmaceutical company, announced on Jun. 1st that it has successfully obtained final approval from the Indonesia...
June 02, 2023 | News
Shimadzu Collaborates with Osaka University, Hires Master's Graduates for Joint Research
Shimadzu and Osaka University have been collaborating to help Shimadzu engineers and researchers obtain doctoral degrees within the REACH Lab Project since...
June 01, 2023 | News
Merck Study: mRNA Technology a ‘Game Changer’ for Asia-Pacific Vaccine Manufacturers
87% of respondents deemed mRNA a key modality for the future More than 60% of vaccine makers surveyed plan revamp or new facilities for mRNA m...
June 01, 2023 | News
Immorna Initiates Phase 1 Study of JCXH-105, a Self-Replicating RNA-Based Shingles Vaccine
"The initiation of our FIH study with JCXH-105 is an important milestone for Immorna and for the development of a potential innovative vaccine for Shingles...
May 31, 2023 | News
Menarini Group's ORSERDU® (Elacestrant) Study Advances in Metastatic Breast Cancer
ORSERDU (elacestrant) was approved by the FDA in January 2023 for advanced or metastatic estrogen receptor (ER)-positive, human epidermal growth factor (...
May 30, 2023 | News
Keio and Osaka Universities Present Non-Clinical Data on Stable/Functional-Induced Regulatory T Cells in Autoimmune Models
Their presentation demonstrated that in a murine pemphigus model, S/F-iTregs significantly decreased clinical scores, circulating anti-Dsg3 IgG titers, and...
May 30, 2023 | News
Thermo Fisher Scientific and BRIN to Strengthen Research Infrastructure and Capabilities in Indonesia
Thermo Fisher, the world leader in serving science, has signed a Memorandum of Understanding ("MOU") with the National Research and Innovation Agency of&nb...
May 26, 2023 | News
Most Read
- Lack of Regular Screening Fuels Rise in Late-Stage Breast Cancer in Hong Kong, New Report Reveals
- BIOCHINA 2025: Connecting Global Innovators with China's Leading Biotech Firms
- Leon Wyszkowski, President of Analytical Services, Discusses Thermo Fisher's Strategic Move: Expanding Bioanalytical Capabilities in Europe with New Sweden Lab
- The Role of Policy and Public Health Initiatives in Addressing Women's Cancer Care in Asia
- Redefining Patient Safety in the Age of Healthtech
Bio Jobs
- Avance Clinical Appoints Jessica Han as Director of Asian Operations, Strengthening Commitment to the Asian Market
- Bristol Myers Squibb Employees Cycle Coast-to-Coast to Raise $1 Million for Cancer Research
- Pfizer Australia Commits $150M to Upgrade Melbourne Facility, Bolstering Global Fight Against Antimicrobial Resistance
- SMi Systems Appoints Dr. Stefan Hamill as Vice President of Strategy to Drive Commercialisation and Growth
- Thermo Fisher Scientific Appoints William Hung as Senior Director and General Manager for Taiwan
- Cytiva Appoints Industry Veteran Pierre-Alain Ruffieux as Chief Operating Officer
News
Editor Picks
